Yelian Garcia

Yelian Garcia Discusses 7 Biotechnology Trends to Watch in 2019

Biotechnology had a mixed bag year in 2018. Some breakthrough drugs, like the RNA interference treatment Onpattro™ (patisiran), made it to market while Atabecestat (JNJ-54861911), a promising Alzheimer’s therapy, failed to secure approvals. 2018 also saw continued consolidation of the biopharma industry as major pharmaceutical companies went after smaller biotech firms with strong drug pipelines.

Read more here:

Leave a Reply

Your email address will not be published. Required fields are marked *